阿托瓦斯塔丁增强了LDL受体介导的LDL-C吸收,并调节了胰腺β细胞中的PCSK9蛋白表达
Zhiyan Zhang1,2, Huadong Zheng2,3, Lusha Zhang2
1Engineering Research Center of Brain Health Industry of Chinese Medicine, Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine of Shaanxi Administration of Traditional Chinese Medicine, Department of Pharmacology, Shaanxi University of Chinese Medicine, Xianyang, China.
Islets
|March 16, 2025
概括
像阿托瓦斯塔丁这样的他类药物可能会通过影响胰腺细胞增加2型糖尿病的风险. 这项研究表明,阿托瓦斯塔丁对LDL受体和胆固醇吸收有影响,可能会影响胰岛素的释放,同时促进细胞生长.
科学领域:
- 内分泌学 在内分泌学.
- 心血管药理学心血管药理学
- 细胞生物学 细胞生物学
背景情况:
- 类药物有效降低LDL-C,用于预防心血管疾病.
- 截然不同的是,他类药物的使用与2型糖尿病 (T2D) 风险的增加有关.
- 需要阐明他类药物的糖尿病性机制,特别是胰腺β细胞的糖尿病性机制.
研究的目的:
- 研究LDL受体 (LDLR) 和PCSK9在阿托瓦斯塔丁对胰腺β细胞的糖尿病效应中的作用.
- 评估阿托瓦斯塔丁对LDL-C吸收,PCSK9表达,葡萄糖刺激胰岛素释放 (GSIR) 和β细胞增殖的影响.
主要方法:
- 使用了MIN6胰腺β细胞系和C57BL/6j小鼠模型.
- 采用了细胞胆固醇测定,EDU标记,Dil-LDL吸收,西斑,RT-qPCR和ELISA.
- 测量了LDLR,PCSK9,LDL-C吸收,GSIR和细胞增殖的变化.
主要成果:
- 阿托瓦斯塔丁上调了LDLR,增强了LDL-C的吸收,而没有细胞胆固醇过载.
- 阿托瓦斯塔丁抑制了PCSK9的表达,减少了LDLR的降解.
- 联合阿托瓦斯塔丁和LDL-C降低了GSIR,但在体外促进了β细胞的增殖;在体内观察到血PCSK9和胰岛素的减少.
结论:
- 阿托瓦斯塔丁可以通过通过LDLR和LDL-C调节对胰腺β细胞功能产生不利影响,从而增加T2D风险.
- 这些发现突出了与他类药物相关的糖尿病的潜在机制.
- 需要进一步的研究,以减轻他类药物的糖尿病性作用,同时保持心血管益处.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
588
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
588
01:05Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
01:29Cholesterol: Significance and Regulation
519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
519
01:58Cell Specific Gene Expression
13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
01:23Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178